Cargando…
The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model
AIMS: Valid health economic models are essential to inform the adoption and reimbursement of therapies for diabetes mellitus. Often existing health economic models are applied in other countries and settings than those where they were developed. This practice requires assessing the transferability o...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156453/ https://www.ncbi.nlm.nih.gov/pubmed/35445871 http://dx.doi.org/10.1007/s00592-022-01891-2 |
_version_ | 1784718454956228608 |
---|---|
author | Emamipour, Sajad Pagano, Eva Di Cuonzo, Daniela Konings, Stefan R. A. van der Heijden, Amber A. Elders, Petra Beulens, Joline W. J. Leal, Jose Feenstra, Talitha L. |
author_facet | Emamipour, Sajad Pagano, Eva Di Cuonzo, Daniela Konings, Stefan R. A. van der Heijden, Amber A. Elders, Petra Beulens, Joline W. J. Leal, Jose Feenstra, Talitha L. |
author_sort | Emamipour, Sajad |
collection | PubMed |
description | AIMS: Valid health economic models are essential to inform the adoption and reimbursement of therapies for diabetes mellitus. Often existing health economic models are applied in other countries and settings than those where they were developed. This practice requires assessing the transferability of a model developed from one setting to another. We evaluate the transferability of the MICADO model, developed for the Dutch 2007 setting, in two different settings using a range of adjustment steps. MICADO predicts micro- and macrovascular events at the population level. METHODS: MICADO simulation results were compared to observed events in an Italian 2000–2015 cohort (Casale Monferrato Survey [CMS]) and in a Dutch 2008–2019 (Hoorn Diabetes Care Center [DCS]) cohort after adjusting the demographic characteristics. Additional adjustments were performed to: (1) risk factors prevalence at baseline, (2) prevalence of complications, and (3) all-cause mortality risks by age and sex. Model validity was assessed by mean average percentage error (MAPE) of cumulative incidences over 10 years of follow-up, where lower values mean better accuracy. RESULTS: For mortality, MAPE was lower for CMS compared to DCS (0.38 vs. 0.70 following demographic adjustment) and adjustment step 3 improved it to 0.20 in CMS, whereas step 2 showed best results in DCS (0.65). MAPE for heart failure and stroke in DCS were 0.11 and 0.22, respectively, while for CMS was 0.42 and 0.41. CONCLUSIONS: The transferability of the MICADO model varied by event and per cohort. Additional adjustments improved prediction of events for MICADO. To ensure a valid model in a new setting it is imperative to assess the impact of adjustments in terms of model accuracy, even when this involves the same country, but a new time period. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00592-022-01891-2. |
format | Online Article Text |
id | pubmed-9156453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-91564532022-06-02 The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model Emamipour, Sajad Pagano, Eva Di Cuonzo, Daniela Konings, Stefan R. A. van der Heijden, Amber A. Elders, Petra Beulens, Joline W. J. Leal, Jose Feenstra, Talitha L. Acta Diabetol Original Article AIMS: Valid health economic models are essential to inform the adoption and reimbursement of therapies for diabetes mellitus. Often existing health economic models are applied in other countries and settings than those where they were developed. This practice requires assessing the transferability of a model developed from one setting to another. We evaluate the transferability of the MICADO model, developed for the Dutch 2007 setting, in two different settings using a range of adjustment steps. MICADO predicts micro- and macrovascular events at the population level. METHODS: MICADO simulation results were compared to observed events in an Italian 2000–2015 cohort (Casale Monferrato Survey [CMS]) and in a Dutch 2008–2019 (Hoorn Diabetes Care Center [DCS]) cohort after adjusting the demographic characteristics. Additional adjustments were performed to: (1) risk factors prevalence at baseline, (2) prevalence of complications, and (3) all-cause mortality risks by age and sex. Model validity was assessed by mean average percentage error (MAPE) of cumulative incidences over 10 years of follow-up, where lower values mean better accuracy. RESULTS: For mortality, MAPE was lower for CMS compared to DCS (0.38 vs. 0.70 following demographic adjustment) and adjustment step 3 improved it to 0.20 in CMS, whereas step 2 showed best results in DCS (0.65). MAPE for heart failure and stroke in DCS were 0.11 and 0.22, respectively, while for CMS was 0.42 and 0.41. CONCLUSIONS: The transferability of the MICADO model varied by event and per cohort. Additional adjustments improved prediction of events for MICADO. To ensure a valid model in a new setting it is imperative to assess the impact of adjustments in terms of model accuracy, even when this involves the same country, but a new time period. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00592-022-01891-2. Springer Milan 2022-04-21 2022 /pmc/articles/PMC9156453/ /pubmed/35445871 http://dx.doi.org/10.1007/s00592-022-01891-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Emamipour, Sajad Pagano, Eva Di Cuonzo, Daniela Konings, Stefan R. A. van der Heijden, Amber A. Elders, Petra Beulens, Joline W. J. Leal, Jose Feenstra, Talitha L. The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model |
title | The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model |
title_full | The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model |
title_fullStr | The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model |
title_full_unstemmed | The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model |
title_short | The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model |
title_sort | transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the micado model |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156453/ https://www.ncbi.nlm.nih.gov/pubmed/35445871 http://dx.doi.org/10.1007/s00592-022-01891-2 |
work_keys_str_mv | AT emamipoursajad thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT paganoeva thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT dicuonzodaniela thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT koningsstefanra thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT vanderheijdenambera thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT elderspetra thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT beulensjolinewj thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT lealjose thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT feenstratalithal thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT emamipoursajad transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT paganoeva transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT dicuonzodaniela transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT koningsstefanra transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT vanderheijdenambera transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT elderspetra transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT beulensjolinewj transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT lealjose transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel AT feenstratalithal transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel |